Background In recent times, anti-cancer treatments have focused on Fibroblast Growth Factor (FGF) and Vascular-Endothelial Growth Factor (VEGF) pathway inhibitors so as to …
E Liow, N Howard, CH Jung, B Pope… - Clinical Genitourinary …, 2022 - Elsevier
Background Disease recurrence is common following prostatectomy in patients with localised prostate cancer with high-risk features. Although androgen deprivation therapy …
RS Silva, LA Kido, F Montico… - Cell biology …, 2018 - Wiley Online Library
Prostate cancer is the second most diagnosed cancer in the world, and alternative methods to prevent and treat different lesion grades need to be evaluated. The objective was to …
F Montico, LA Kido, AC Hetzl, VHA Cagnon - The Prostate, 2015 - Wiley Online Library
BACKGROUND Aging is considered one of the main predisposing factors for the development of prostate malignancies. Angiogenesis is fundamental for tumor growth and …
H Ruetten, KA Wegner, MF Romero, MW Wood… - The …, 2018 - Wiley Online Library
Background Prostate stiffness and increased collagen content both associate with the presence of urinary symptoms in men but mechanisms responsible, including impact of age …
LA Kido, AC Hetzl, EM Cândido, F Montico… - Life sciences, 2014 - Elsevier
Aims The aim of this study was to evaluate the structural and molecular effects of antiangiogenic therapies and finasteride on the ventral prostate of senile mice. Main …
DJ Taatjes, J Roth - Histochemistry and Cell Biology, 2015 - Springer
This review encompasses a brief synopsis of the articles published in 2014 in Histochemistry and Cell Biology. Out of the total of 12 issues published in 2014, two special …
AC Hetzl, F Montico, LA Kido, VHA Cagnon - Tissue and Cell, 2016 - Elsevier
The aim of this study was to characterize and relate the prolactin (PR), epidermal growth factor receptor (EGFR), α-actin and vimentin immunoreactivity in the prostate of elderly rats …